Nothing Special   »   [go: up one dir, main page]

Heredia, 2019 - Google Patents

Conformational engineering of human chemokine receptors and HIV-1 Env using deep mutational scanning

Heredia, 2019

View PDF
Document ID
9472062396611271658
Author
Heredia J
Publication year

External Links

Snippet

Experimental analysis of protein mutations is classically a 'small data'problem. A limited number of mutants are made at sites of suspected importance, and the activity of each variant is individually tested. However, by combining directed evolution and deep …
Continue reading at www.ideals.illinois.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Similar Documents

Publication Publication Date Title
JP6535361B2 (en) Fusion protein containing modified knottin peptide and use thereof
Doria-Rose et al. New member of the V1V2-directed CAP256-VRC26 lineage that shows increased breadth and exceptional potency
Dürkop et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
KR20230052910A (en) CCR8 antibody and its application
KR20210019993A (en) Τ Cell receptor and engineered cells expressing it
US20110077163A1 (en) Reverse Transfection Of Cell Arrays For Structural And Functional Analyses Of Proteins
Maerz et al. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association
JP2006524827A (en) Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof
US20100249022A1 (en) Strategy for cloning and expressing the extracellular domains of receptors as soluble proteins
Constantinescu et al. Activation of the erythropoietin receptor by the gp55‐P viral envelope protein is determined by a single amino acid in its transmembrane domain
Nangola et al. Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein
Choi et al. A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry
Ray-Saha et al. Antibody epitopes on g protein-coupled receptors mapped with genetically encoded photoactivatable cross-linkers
Heredia et al. Conformational engineering of HIV-1 Env based on mutational tolerance in the CD4 and PG16 bound states
Riggs et al. The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC
Scurci et al. CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties
Zhou et al. Structural features of broadly neutralizing antibodies and rational design of vaccine
He et al. Single methyl groups can act as toggle switches to specify transmembrane Protein-protein interactions
KR20210091220A (en) Non-native NKG2D receptor that does not signal directly to adherent cells
Heredia Conformational engineering of human chemokine receptors and HIV-1 Env using deep mutational scanning
US20050158724A1 (en) Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
JP2023523828A (en) Detection Reagents and Detection Methods for Screening Blockers of Coronavirus Infection
Gill A study of viral entry proteins and receptors using deep mutagenesis
Sundbäck et al. NK cell inhibitory receptor Ly-49C residues involved in MHC class I binding
Königs et al. Peptide mimotopes selected with HIV‐1‐blocking monoclonal antibodies against CCR5 represent motifs specific for HIV‐1 entry